Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

27,642 signal articles · 217 in last 24h · 133,962 total before filter · latest 54m ago
217last 24h
1091last 7d
172● bullish (7d)
132● bearish (7d)
208publishers
AllMacro293Earnings366M&A73Regulatory28Product10Analyst16
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
How Investors Are Reacting To Ares Management (ARES) Strong Q2 Earnings and Affirmed Dividends
Simply Wall St.22d agoneutral
How Investors Are Reacting To Ares Management (ARES) Strong Q2 Earnings and Affirmed Dividends

Ares Management Corporation recently reported past second-quarter 2026 results, with revenue of US$1,428.61 million and net income of US$150.64 million, alongside declaring quarterly dividends of US$1.35 per share for its common stock and US$0.84375 per share for its 6.75% Series B mandatory convertible preferred stock. The combination of higher year-on-year revenue and earnings, together with continued common and preferred dividends, highlights Ares Management’s ability to translate its...

Bullish (BLSH) Stock May Sit Above Fair Value Even After A 38% Fall
Simply Wall St.22d agobearish
Bullish (BLSH) Stock May Sit Above Fair Value Even After A 38% Fall

Bullish stock has fallen about 37.5% year to date, yet its valuation checks still do not flag it as a clear bargain. This raises questions about how much of the recent weakness is already reflected in the price. The year to date decline of roughly 37.5% suggests sentiment around Bullish has cooled sharply, even before any potential change in fundamentals is fully assessed. Bullish’s role in supporting Elemental Royalty’s recent Tether Gold dividend option may support the case for its digital...

Pfizer (PFE) Agreed To A $44 Million Chantix Settlement
Simply Wall St.22d agoneutral
Pfizer (PFE) Agreed To A $44 Million Chantix Settlement

Pfizer (NYSE:PFE) agreed to a US$44 million class action settlement related to its smoking cessation drug Chantix, addressing claims tied to product safety disclosures. The company reported positive topline Phase 3 results for LITFULO in adults and adolescents with nonsegmental vitiligo, highlighting progress in its immunology pipeline. Both developments arrive as investors track Pfizer's legal exposures alongside late stage trial data that could inform future portfolio and revenue...

3 Restaurant Stocks That Concern Us
StockStory22d agoneutral
3 Restaurant Stocks That Concern Us

From fast food to fine dining, restaurants play a vital societal role. But it’s not all sunshine and rainbows as they’re notoriously hard to run thanks to perishable ingredients, labor shortages, or volatile consumer spending. These factors have weighed on the industry over the past six months as its 3.7% return has fallen short of the S&P 500’s 11% gain.

Shares are mostly higher in Asia, with Kospi up 4%, while oil prices gain
Associated Press22d agoneutral
Shares are mostly higher in Asia, with Kospi up 4%, while oil prices gain

Asian shares were mostly higher Wednesday after U.S. stocks slipped a bit further from their records, while oil prices advanced as doubts persisted over when the war with Iran will allow crude to flow freely again. Samsung Electronics gained 7.7% and memory chipmaker SK Hynix was up 7.1%. The price of a barrel of Brent crude, the international standard, was up 0.9% at $89.67 early Wednesday.

Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga Prediction Markets22d agoneutral
Stock Market: Will S&P 500 Open Up or Down Today?

U.S. stock futures are showing modest gains early Wednesday, as investors digest a mix of robust corporate earnings against the backdrop of an intensifying geopolitical impasse in the Middle East and an expected read on U.S. inflation. The Polymarket (CRYPTO:...

2 Russell 2000 Stocks to Target This Week and 1 We Turn Down
StockStory22d agobearish
2 Russell 2000 Stocks to Target This Week and 1 We Turn Down

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

1 of Wall Street’s Favorite Stocks on Our Buy List and 2 Facing Challenges
StockStory22d agobullish
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 Facing Challenges

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Gary Black Says Investors ‘Losing Faith’ That Tesla Can Scale Autonomy—Blames Elon Musk’s Vision-Only Approach
Benzinga22d agoneutral
Gary Black Says Investors ‘Losing Faith’ That Tesla Can Scale Autonomy—Blames Elon Musk’s Vision-Only Approach

Investor Gary Black believes Tesla Inc.’s (NASDAQ:TSLA) pullback in its self-driving ambitions is causing investors to lose faith that the company will eventually solve autonomy. Gary Black Outlines ‘Fundamental’ Reason Behind Robotaxi Slowdown In a series of posts on X, The Future Fund LLC co-founder opined that there was “some fundamental reason” behind Tesla slowing down its unsupervised Full Self-Driving (FSD) and Robotaxi targets. Read Also: Tesla Burns Through Funds Allocated for Gavin New

Array Digital Infrastructure Q2 Earnings Call Highlights
MarketBeat22d agoneutral
Array Digital Infrastructure Q2 Earnings Call Highlights

TDS reported second-quarter progress in its fiber expansion and tower infrastructure operations, while updating 2026 guidance for both TDS Telecom and Array Digital Infrastructure (NYSE:AD). Management also said it would not provide further updates or take questions regarding TDS’s pending proposal

3 Profitable Stocks We’re Skeptical Of
StockStory22d agoneutral
3 Profitable Stocks We’re Skeptical Of

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Babcock & Wilcox Enterprises (BW) Returns To Profit, Is It Still A Bargain?
Simply Wall St.22d agoneutral
Babcock & Wilcox Enterprises (BW) Returns To Profit, Is It Still A Bargain?

Babcock & Wilcox Enterprises (BW) moved into focus after its Q2 2026 report showed a return to profit, strong year over year sales growth, record backlog, and higher full year guidance. See our latest analysis for Babcock & Wilcox Enterprises. Babcock & Wilcox Enterprises has been volatile, with the share price down 21% over the past month and 53% over the past quarter, yet still showing a 45% year to date share price return and a very large 1 year total shareholder return that reflects...

NIO (NYSE:NIO) Draws A Bigger Institutional Stake
Simply Wall St.22d agoneutral
NIO (NYSE:NIO) Draws A Bigger Institutional Stake

IMC-Chicago has significantly raised its equity stake in NIO (NYSE:NIO) as part of a recent portfolio reshuffle in the EV sector. The firm has reduced positions in several other electric vehicle competitors while exiting select holdings entirely. The move concentrates more of IMC-Chicago's EV exposure in NIO compared with other stocks in the segment. NIO is far from the only stock tied to this theme. It can be useful to look across a broader group of related companies through 19 elite penny...

Nutrien (TSX:NTR) Stock May Be 36% Undervalued On Cash Flow
Simply Wall St.22d agoneutral
Nutrien (TSX:NTR) Stock May Be 36% Undervalued On Cash Flow

Nutrien stock has delivered a 44.5% total return over the past five years, and the current Discounted Cash Flow (DCF) intrinsic value estimate still points to material upside at a 36.2% discount to that estimate. At the same time, traditional earnings and asset based valuation checks show a more mixed picture, with the stock screening as about right on market multiples. Nutrien's 44.5% total return over five years suggests the market has already priced in a meaningful portion of the...